Merck & co., inc. (MRK)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09
Cash Flows from Operating Activities
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

3,219

2,363

1,908

2,644

2,862

1,778

1,958

1,716

741

-1,038

-51

1,951

1,556

-587

2,189

1,209

1,130

982

1,831

688

958

7,327

843

2,033

1,731

815

1,151

935

1,616

949

1,763

1,820

1,767

1,543

1,724

2,054

1,071

-500

372

780

330

6,522

3,455

1,588

1,455

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and Amortization

821

936

845

973

898

998

1,094

1,290

1,137

1,167

1,154

1,162

1,193

1,185

1,175

1,550

1,561

1,560

1,570

1,608

1,637

1,573

1,611

1,753

1,754

1,954

1,705

1,655

1,674

1,661

1,723

1,804

1,790

1,861

1,903

1,832

1,831

1,866

1,880

1,948

1,687

1,249

393

489

443

Intangible asset impairment charges

0

176

612

148

104

296

0

0

0

270

245

51

80

3,376

5

290

277

82

7

59

14

13

549

660

0

171

0

564

30

24

40

127

9

244

22

137

302

2,225

189

0

27

-

-

-

-

Charge for future payments related to collaboration license options

-

-

-

-

-

0

0

0

650

-250

750

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity income from affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5

63

2

145

16

24

93

124

53

102

116

133

232

157

143

110

256

161

55

138

170

237

42

138

373

688

587

585

Dividends and distributions from equity method affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

5

4

3

53

7

59

66

59

110

63

5

110

59

56

66

30

65

56

65

60

82

105

77

245

518

503

456

Deferred income taxes

82

-170

-237

-343

194

-118

-133

-228

-30

-2,020

-329

-218

-54

-1,456

55

-50

-70

82

-463

-204

-179

-827

-527

-942

-304

202

-213

-248

-71

952

82

-324

-41

-563

-133

-627

-214

-349

-424

-471

152

-88

1,259

495

153

Share-based Payment Arrangement, Noncash Expense

108

111

102

111

93

87

91

90

80

80

76

82

74

75

77

80

68

78

75

83

63

69

75

78

56

66

68

75

67

78

88

93

76

82

87

107

93

109

126

142

132

133

84

83

113

Other

-143

35

-105

6

-120

-490

-123

-315

-50

-221

94

-91

28

-13

-34

-84

-82

-59

-126

-138

-551

-480

254

77

115

28

85

-46

-326

-62

177

-72

-71

-530

-249

234

222

-150

183

-571

161

1,066

-300

-321

90

Net changes in assets and liabilities:
Net changes in assets and liabilities

3,666

-3,437

91

443

2,935

-1,360

760

-199

1,473

-4,172

2,922

-198

2,535

-3,239

564

1,563

875

-782

-223

392

618

1,048

-2,068

415

703

-1,057

-1,315

636

1,173

-1,138

282

585

1,474

-402

-821

418

1,067

942

-787

-1,057

1,062

-5,293

2,272

4,332

-1,414

Net Cash Provided by Operating Activities

707

4,794

4,226

3,084

1,336

3,592

2,793

3,382

1,155

4,019

-1,171

3,317

286

3,632

2,971

1,600

2,173

4,246

3,311

2,697

2,284

-1,035

4,348

2,315

2,361

3,026

3,949

2,338

2,341

1,809

3,139

2,920

2,154

3,233

4,577

2,852

1,721

3,539

2,592

3,325

1,366

2,242

-312

749

712

Cash Flows from Investing Activities
Capital expenditures

986

1,137

959

782

595

929

653

583

450

715

441

393

339

551

409

375

279

493

316

271

203

490

320

302

205

429

355

413

351

778

414

431

331

603

431

365

324

660

338

337

343

557

303

365

235

Purchases of securities and other investments

49

822

570

836

974

1,095

1,651

3,922

1,326

2,342

2,117

3,351

2,929

5,567

3,729

3,988

2,367

4,256

3,804

3,582

5,039

8,713

3,851

5,555

6,825

4,914

4,259

4,808

4,010

5,950

2,890

1,276

2,725

2,639

1,620

1,684

1,382

1,371

1,591

1,302

2,933

319

97

609

2,045

Proceeds from sales of securities and other investments

1,816

1,163

2,524

3,036

1,899

4,009

3,840

5,555

1,848

3,131

3,170

2,544

6,819

3,053

3,912

2,768

4,620

3,882

3,903

6,341

6,287

3,307

3,705

5,470

2,632

6,475

2,628

4,034

3,161

2,176

1,433

1,377

2,797

1,409

1,850

1,366

1,524

835

2,026

1,427

273

596

4,506

2,719

3,119

Acquisition of Peloton Therapeutics, Inc., net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

7,598

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition of ArQule, Inc., net of cash acquired

2,545

25

-1

270

0

-

-

-

-

49

0

41

306

2

621

10

147

36

110

0

0

181

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

104

11

10

131

0

0

0

130

Dispositions of businesses, net of cash divested

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

121

490

25

533

46

0

0

0

-

-

-

-

0

0

17

306

-

-

-

-

-

-

-

-

Decrease in restricted assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-25

-11,015

3,916

866

684

Other

-136

-58

-235

-47

-38

-252

-124

5

269

83

-59

-114

52

-504

43

-107

86

-121

-140

-12

52

-14

46

106

-58

105

51

-52

-47

-115

-32

-32

11

-60

62

9

19

-17

-108

-14

-11

-177

11

-7

3

Net Cash (Used in) Provided by Investing Activities

-1,628

-763

191

-2,425

368

2,178

1,660

673

-197

-58

671

-1,127

3,193

-2,563

-890

-1,498

1,741

-617

-61

2,525

-6,605

7,204

-3,722

-49

-3,807

1,177

-2,037

-1,135

-1,153

-4,398

-1,839

-298

-270

-1,684

-263

-1,048

105

-1,007

194

464

-3,148

-12,864

12,011

2,618

1,390

Cash Flows from Financing Activities
Net change in short-term borrowings

3,583

182

-360

603

-4,135

2,830

225

2,070

-1

-1,988

1,986

-3,808

3,784

-909

918

-9

0

-14

3

-3,706

2,177

-3,537

4,963

-5,035

3,149

-310

-1,551

822

880

904

-1,917

1,003

634

-280

-40

1,593

-197

-1,483

-85

-962

2,620

-1,018

-1,618

-297

511

Payments on debt

1,951

0

0

0

0

1,280

-1

2,005

1,003

802

0

1

300

0

35

1,500

851

1

0

3

2,902

6,610

2

2

3

1,260

0

9

506

18

2

0

2

-

-

-

-

652

63

4

622

0

17

0

7

Proceeds from issuance of debt

0

0

0

0

4,958

0

0

0

0

-

-

-

-

-

-

-

-

0

-2

-1

7,941

3,145

0

1

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of treasury stock

1,281

1,050

1,405

1,235

1,090

5,933

996

1,596

566

1,702

159

1,134

1,019

1,016

845

660

913

1,181

1,281

709

1,015

1,620

2,670

2,246

1,167

196

215

5,525

580

1,152

454

529

456

-

-

-

-

-

-

-

-

-

-

-

-

Dividends paid to stockholders

1,551

1,405

1,394

1,468

1,428

1,277

1,285

1,311

1,299

1,283

1,283

1,307

1,294

1,271

1,274

1,300

1,279

1,263

1,272

1,302

1,280

1,259

1,282

1,339

1,290

1,260

1,259

1,332

1,306

1,280

1,277

1,280

1,279

1,165

1,175

1,176

1,175

1,175

1,181

1,189

1,189

804

803

803

803

Proceeds from exercise of stock options

26

17

40

131

173

130

162

69

230

18

73

95

313

149

409

179

202

51

57

135

242

179

247

203

931

401

168

549

92

250

459

222

379

127

32

125

37

50

76

42

195

178

4

2

0

Other

-316

245

-33

-115

-92

-36

-12

-194

-83

-28

-81

-63

-23

-9

-8

-76

-25

2

-44

-11

-8

7

23

49

0

121

-58

-2

-1

140

-51

-2

-1

39

-4

-220

163

85

-76

-53

-62

59

62

-154

-93

Net Cash Used in Financing Activities

-1,490

-2,011

-3,152

-2,084

-1,614

-5,566

-1,905

-2,967

-2,722

-5,785

536

-6,218

1,461

-1,977

-835

-3,366

-2,866

-2,406

-2,539

-5,597

5,155

-9,772

1,279

-8,369

1,620

-2,624

-2,915

970

-1,421

-1,218

-738

-586

-725

-2,231

-2,244

-1,257

-1,172

-1,295

-1,625

-3,463

942

-1,849

-2,372

2,975

-391

Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash

-63

43

-54

8

20

-65

-32

-262

154

19

79

106

253

-484

53

156

144

-247

-85

-683

-295

-326

-278

18

33

-48

3

-107

-194

-102

46

60

-34

-40

-159

100

141

-211

47

104

-235

-34

32

97

-62

Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash

-2,474

2,063

1,211

-1,417

110

139

2,516

826

-1,610

-1,805

115

-3,922

5,193

-1,392

1,299

-3,108

1,192

976

626

-1,058

539

-3,929

1,627

-6,085

207

1,531

-1,000

2,066

-427

-3,909

608

2,096

1,125

-722

1,911

647

795

1,026

1,208

430

-1,075

-12,505

9,359

6,440

1,648